Contrasting effects of proinflammatory and T.helper lymphocyte subset-2 cytokines on the 5-lipoxygenase pathway in monocytes. Human peripheral blood monocytes (HPBMs) express 5-lipoxygenase (5-LO) and 5-LO activating protein (FLAP), and hence have an ability to synthesize proinfiammatory leukotrienes (LTs). Regulation of 5-LO and FLAP expression is a major determinant of cellular LT synthesis. We examined the effects of proinflammatory [interleukin (IL)-1 and interferon (IFN)-y] and T helper lymphocyte subset 2 (TH-2; IL-4 and IL-13) cytokines on (1) LTB4 production, and (2) 5-LO and FLAP expression in HPBMs. We show that IL-i and IFN-y stimulate, whereas IL-4 and IL-13 inhibit ionophore-activated LTB4 release. The stimulatory effects of IL-I and IFN-y were apparent at 16 to 36 hours of incubation. IL-i modestly increased FLAP mRNA and significantly increased 5-LO mRNA steady state levels at 24 and 36 hours of incubation, respectively. IFN-y did not change the mRNA or protein expression of either 5-LO or FLAP. The inhibitory effects of IL-4 and IL-13 were associated with decreased FLAP mRNA and protein steady state levels. These results demonstrate that regulation of monocyte LTB4 biosynthesis by different cytokines proceeds via different pathways that partly involve modulation of the expression of the key proteins, 5-LO and FLAP. In addition, the contrasting effects of proinfiammatory and TH-2-derived cytokines on moneyte LTB4 production demonstrate mechanisms by which cytokine subpopulations may modulate monocyte function in inflammation.
potent neutrophil chemotactic agent. It also causes neutrophil activation and degranulation, and enhances neutrophil-endothehal cell adhesion. LTC4 and LTD4 mediate vasoconstriction, increase vascular permeability to macromolecules, and enhance mucous secretion in a variety of vascular beds [6, 7] .
Monocyte recruitment and activation is an integral component of immunologic and inflammatory responses. Cytokines, which are released at inflammatory sites, modulate monocyte responses [8] [9] [10] [11] [12] [13] . In this regard, proinflammatory cytokines such as IL-i and IFN-y induce monocyte activation and monokine release [8-101. On the other hand, lymphokines produced by the helper Tlymphocyte subset 2 (TH-2) cells, such as IL-4 and IL-13, downregulate the inflammatory actions of monocytes [11] [12] [13] . They suppress monocyte production of monokines and increase the synthesis of IL-i receptor antagonist. The possibility that promflammatoiy [IL-i and 1FN-yJ and TH-2-derived [IL-4 and IL -13] cytokines differentially regulate the 5-LO pathway in monocytes has not been fully explored. We and others have already demonstrated reciprocal regulation of monocyte 15-LO by TH-I and TH-2 lymphokines [14, 15] . The 15-LO enzyme catalyzes another major pathway of arachidonic acid metabolism in monocytes that generates 15-S-HETE and lipoxins, products that antagonize LTs, and exert anti-inflammatory effects [16] [17] [18] . IL-4 and IL-13 induced monocyte 15-LO, whereas IFN-y suppressed 15-LO induction by either cytokine [14, 15] .
In the present study, we examined the effects of proinflammatory (IL-i and IFN-y) and TH-2-derived (IL-4 and IL-13) cytokines on LTB4 production by cultured human peripheral blood monocytes. We also examined the effects of these cytokines on monocyte 5-LO and FLAP expression. We demonstrate contrasting effects of proinflammatory and TH2-derived cytokines on the monocyte 5-LO pathway.
Methods

Materials
Recombinant human 1L-ip, 1L-4, and IL-13 were purchased form R&D systems (Minneapolis, MN, USA) with a manufacturer's ED5O value of 3 to 10 pg/ml (murine helper T-cell line D10.G4.1), 0.3 to 0.9 ng/ml (murine TH-2 cell line), and 3 to 6 ng/ml (human factor-dependent cell line, TF-1) respectively.
Recombinant IFN-y was purchased from Boehringher Mannheim (Indianapolis, IN, USA) with a specific activity of 2 x i07 U/mg (inhibition of cytopathic effect of EMC virus on human amniotic cells). Human 5-LO and FLAP cDNAs and antibodies were a gift from Merck Frosst Laboratories (Canada). Enzyme linked immunoassay kits for LTB4 measurement were purchased from Elisa Technologies (Neogen Corporation, Lexington, KY, USA). DNA oligolabeling kits were purchased from Pharmacia Biotech Inc. (Piscataway, NJ, USA). ECL kits for Western blot analysis were obtained from Amersham (Arlington Heights, IL, USA).
Monocyte isolation and incubation
Fresh buffy coats were obtained from healthy volunteers (American Red Cross, Atlanta, GA, USA) and subjected to (pH = 7.5), and unless otherwise specified, the adherent cells were incubated in 10% fetal calf serum-enriched RPM! medium (37°C, 5% C02) with cytokine or its diluent (control). The latter constituted of 0.1% bovine serum albumin in PBS. In initial experiments the adherent cells were scraped and counted. The number of adherent cells was nearly 20% of the initial number of plated cells. More than 90% of the adherent cells stained positive for monocyte nonspecific esterase, and more than 95% were viable by trypan blue exclusion. Cell viability up to 36 hours of incubation with and without cytokine was 92 to 94%.
Measurement of L TB4 release
Following incubation with cytokine (or its diluent), monocytes were washed twice with PBS and reincubated for 30 minutes in serum-free complete RPMI-1640 medium with 2 fLM of calcium ionophore A23187. The monocyte supernatant was collected for LTB4 measurement, and the adherent cells were scraped and quantitiated for cellular protein using the Bio-Rad protein assay technique (Bio-Rad, Melville, NY, USA). Levels of LTB4 in monocyte supernatants were determined using a specific enzymelinked immunoassay. Results were expressed as ng LTB4 produced per mg of monocyte cellular protein per minute. To ascertain that monocyte cellular protein levels correlated with the number of viable cells following incubation, we scraped adherent cells, counted the viable cells, and then measured the protein content. We found that the various cytokines used did not affect the number of viable cells recovered, and that the number of viable cells correlated with cellular protein measurements.
RNiI isolation and analysis Total cellular RNA was purified from adherent HPBMs by the Chomczynski and Sacchi method using the RNAzoI reagent (Biotecx Laboratories, Houston, TX, USA) [191. Expression of 5-LO and FLAP mRNA were analyzed by Northern hybridization. Total cellular RNA (20 j.tg) was electrophoresed on a 1% formaldehyde-agarose gel, transferred to Hybond-N + membrane (Amersham), and covalently linked by ultraviolet irradiation using a uv cross-linker (Stratagene, La Jolla, CA, USA). Radiolabeled probes were prepared using 100 ng of the respective full length cDNA in a standard protocol for random oligolabeling with [cs32P] dCTP. Approximately 1 to 2 X 106 cpm of radiolabeled probe (specific activity = 1 >< iO dpm/.tg DNA) were used per ml of . 4r
Time, hours hybridization solution. Hybridizations were performed at 42°C for 16 hours. 5-LU blots were washed with a final stringency of 0.2 X SSC, 0.1% SDS at 55°C for 30 minutes, and FLAP blots with a final stringency of 2 >< SSC, 0.1% SDS at 42°C for 30 minutes. Autoradiography was performed using Hyperfilm-MP (Amersham) with an intensifying screen at -70°C for 8 to 12 hours. These RNA blots were afterwards stripped using boiling water with 1% SDS and then reprobed for GAPDH mRNA to ensure equal loading of RNA. All hybridization signals were subjected to computer-assisted densitometric analysis. 5-LO and FLAP densitometry signals were normalized by that of GAPDH. Following the designated incubation time, adherent monocytes were washed in PBS, suspended in lysis buffer (50 mvs HEPES, 1% Triton X-100, 50 mrvi NaC1, 50 mrvi NaF, 10 m sodium pyrophosphate, 5 mvt EDTA, 1 mvt Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 10 mg/liter aprotinin, 10 mg/liter leupeptin), and sonicated for 10 seconds. Cell debris was separated from solubilized protein by centrifugatiori at 1200 X g for 10 minutes.
Protein in the supernatant was quantitated using the Bio-Rad protein assay technique (Bio-Rad). Thirty micrograms of total protein was then separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane using TransBlot SD electrophoretic transfer cell (Bio-Rad). The membrane was probed with rabbit anti-human 5-LO and anti-human FLAP antibodies for one hour following which it was washed with PBS-0.l% Tween. A horseradish peroxidase-labeled anti-rabbit IgG antibody (Amersham) was applied for one hour then washed with PBS-0.I% Tween. The hybridization signal was detected using Enhanced Chemiluminescence (ECL) detection reagents (ECL, Amersham). The ECL reagents were added as described by the manufacturer, and autoradiography was performed at room temperature for one minute.
Statistical methods
Monocyte activated LTB4 release was expressed as mean standard error of the mean. Differences in monocyte activated LTB4 release among various conditions were compared by ANOVA. Student's t-test was used for direct comparisons of activated LTB4 release by cytokine-treated cells and controls.
Differences were considered significant at P < 0.05. Monocyte 5-LO and FLAP mRNA hybridization signal densities in all conditions were normalized by that of GAPDH, and expressed as % change in comparison with controls. Monocyte 5-LO and FLAP Western blotting signals were expressed as % change in comparison with control. The Wilcoxon rank sum test was used to determine if significant differences were present between signals obtained from monocytes incubated with cytokines and controls. Differences were considered significant at P < 0.05.
Results
IL-i and IFN-y enhance monocyte LTB4 release Incubation of monocytes for 36 hours with either IL-i (100 pM) or IFN-y (100 pM) led to enhanced LTB4 release following activation with A23 187 (Fig. IA) . IL-i-treated monocytes had 4.7 times more LTB4 release (331 59 vs. 72 17 ng/mg/hr; N = 10; P < 0.05), and IFN-y-treated monocytes had 3.4 times more LTB4 release (242 54 vs. 72 17 ng!mg!hr; N = 10; P < 0.05) in comparison with controls. To demonstrate a dose-response effect, monocytes were incubated with increasing concentrations of IL-i and IFN-y. Enhancement of LTB4 release by stimulated monocytes was detected with either cytokine at concentrations starting at 10 p, and progressively increased with higher concentrations (Fig. 1B) .
A23 187-activated LTB4 release from control monocytes exhibited a significant and steady decline over 36 hours (Fig. 1C) 16 nglmg/hr at 36 hr; N 4). The time course pattern of activated LTB4 release from monocytes treated with either IL-i or IFN-y was characterized by two phases (Fig. IC) : an initial phase over eight hours in which activated LTB4 release exhibited a steady decline and was similar to control, and a subsequent phase (16 to 36 hr) manifested by an increase in activated LTB4 release to values significantly higher than control.
IL-4 and IL-i3 suppress monocyte LTB4 release
Incubation of monocytcs with either IL-4 (100 pM) or IL-13 (500 pM) for 24 hours led to significant decreases in activated monocyte LTB4 release (Fig. 2) . In comparison with controls, 
FLAP (18 kDa)
IL-4-treated monocytes had 61% less LTB4 release following activation with A23187 (34 11 ng/mglhr vs. 87 19 nglmglhr; N = 5; P < 0.05) ( Fig. 2A) . Similarly, IL-13-treated monocytes had 71% less activated LTB4 release in comparison with controls (25 19 ng/mg/hr vs. 87 19 ng!mglhr; N = 5; P < 0.05). These effects were apparent with IL-4 at 10-1000 p, and with IL-13 at 50-5000 M corresponding to 0.1 ED50 to 10 ED5() for either cytokine (Fig. 2B) . In a time course study, decreased monocyte activated LTB4 release with either IL-4 (100 pM) or IL-13 (500 pM) was significant following 24 hours of incubation, but not at earlier time points (Fig. 2C ).
IL-I increases monocyte 5-LO mRNA expression We next determined if cytokine-mediated changes in activated LTB4 release are associated with changes in monocyte 5-LU mRNA steady state levels. Incubation of monocytes with IL-I (100 pM), but not other cytokines, led to statistically significant increases in 5-LU mRNA levels following (but not prior to) 36 hours of incubation (Fig. 3) . Figure 3A (Fig. 3B ). This increase in 5-LU mRNA signal density was not seen at earlier time points (data not shown). IFN-y treated monocytes had an average 1.5 0.4-fold increase in monocyte 5-LU mRNA levels, which did not reach statistical significance. IL-4-and IL-13-treated monocytes had insignificant changes in 5-LU mRNA expression. All values were standardized by the mRNA expression of the house keeping gene GAPDH.
IL-4 and IL-13 decrease monocyte FLAP ,nRNA expression Similarly, we determined the effects of the same cytokines on monocyte FLAP mRNA expression (Fig. 4) . IL-4 and IL-13 significantly decreased monocyte FLAP mRNA expression at (but not prior to) 24 hours of incubation. Figure 4A shows decreased FLAP mRNA signal intensity with both IL-4 (100 pM) and (500 pM). Analysis of seven such blots (Fig. 4C ) revealed a decrease of 47% 12% (P < 0.05) and 46% 9% (P < 0.05) in FLAP mRNA expression with IL-4 and IL-13, respectively. Figure 4B demonstrates increased FLAP mRNA hybridization signal with IL-I (100 pM) following 36 hours of incubation. In a time course study (N = 3), this increase was noticed as early as 24 hours (136 25% We next determined if cytokine-mediated changes in LTB4 release were associated with changes in monocyte 5-LU or FLAP protein expression (Fig. 5) . Western blot analysis showed that IL-i (100 pM) and IFN-y (100 pM) had no effect of the expression of either protein. Figure 5A Figure 5C . Analysis of three such blots revealed an average 49% decrease in FLAP expression with IL-4, and 57% decrease with IL-13 (P < 0.05). Finally, IL-4 and IL-13 did not change monocyte 5-LU expression as demonstrated in Figure SD .
Discussion
Our results demonstrate that IL-i and IFN-y enhance the release of LTB4 from HPBMs following activation with the calcium ionophore A23187. This effect is dose and time dependent, and occurs at biologically relevant concentrations. In marked contrast to the effects of IL-I and IFN-y, the TH-2 cytokines, IL-4 and IL-13, decrease LTB4 release from A23187-activated monocytes. This effect is time dependent and occurs at biologically relevant concentrations. These contrasting effects on activated monocyte LTB4 release cannot be explained by effects on monocyte viability or adherence which were similar with all cytokines tested and did not differ from control.
Of interest is that cultured monocytes exhibitied spontaneous diminution of A23187-activated LTB4 release during the first 16 hours of incubation. This phenomenon was also reported by other investigators [20] . It remains uncertain whether the in vitro culture conditions cause a decline in monocyte LTB4 synthesis, or the technique of monocyte handling and isolation primes monocytes to higher initial LTB4 synthetic rates. In fact, the isolation technique subjects monocytes to significant physical and biochemical disturbances, and may cause monocyte activation. It is thus possible that initial rates of A23 187-activated LTB4 release are elevated as a reflection of monocyte disturbance during the isolation technique, and that subsequent rates reflect steady state levels. Even though these monocytes in culture do not behave and respond exactly as monocytes in vivo, yet they are structurally and functionally viable cells. Several investigators have cultured HPBMs under similar conditions and tested their responses to cytokine challenge [11, [13] [14] [15] 21] . to reduce monocyte 5-LU activity and diminish LT synthesis [22] [23] [24] . In this regard, the importance of FLAP for expression of 5-LO activity and LT synthesis comes from experiments demonstrating a correlation between expression of FLAP and cellular LT synthesis [23, 24] , and also from the fact that FLAP inhibition by MK886 completely suppresses cellular 5-LO activity [22] .
Our results also show that IL-I increases monocyte 5-LU and FLAP mRNA expression. The increase in steady state 5-LU mRNA levels with IL-I was statistically significant following 36
hours of incubation. The increase in monocyte FLAP mRNA steady state levels was modest and observed at 24 and 36 hours of incubation, but did not reach statistical significance. The biological significance of these increases in steady state mRNA levels of 5-LU and FLAP remains uncertain for two reasons: first, differences in activated LTB4 release between IL-I-treated and control monocytes were notable at 16 hours of incubation (Fig. 1C) , prior Increased expression or activity of enzymes acting downstream to 5-LU such as LTA4 hydrolase may contribute to the increase in stimulated LTB4 production. In this regard, we have recently reported [26] that IFN-y (100 pM) increases monocyte LTA4 hydrolase mRNA expression (Fig. 6) .
IL-i and IFN-y are proinflammatory cytokines produced locally at inflammatory sites. IL-i is largely produced by monocytes and tissue macrophages and acts in several ways to amplify the inflammatory response [81. In this regard, it enhances the proliferation of CD4 positive T cells and the growth and differentiation of B cells. It also acts on macrophages to induce the synthesis of IL-6 and IL-8, which in turn promote leukocyte activation. IFN-y is largely produced by TH-1 cells. It up-regulates MHC class-I and class II antigen expression and is a potent activator of macrophages [9, 10, 27] . In addition to these effects on the immune system, the current results show that IL-I and IFN-y also exert proinflammatory effects by enhancing the release of LTB4 from activated monocytes. In turn, increased LTB4 production is likely to enhance proinflammatory cytokine release by monocytes and T cells, thus further amplifying inflammation [28-301. IL-4 and IL-13 are immunoregulatory lymphokines secreted by TH 2 lymphocytes [31, 32] . These cytokines have already been demonstrated to share several properties most notably their ability to down-regulate monocyte inflammatory responses (11, 33, 34] . They decrease monocyte release of proinflammatoty cytokines such as IL-i and TNF-a, and increase the release of IL-I receptor antagonist [11] . Inhibition of monocyte activated LTB4 release by these lymphokines is in keeping with their other anti-inflammatory effects, and may interrupt the positive feedback loop by which LTB4 enhances proinflammatory cytokine release [28 -30] .
Regulation of the monocyte arachidonate 15-LU by specific cytokines has recently been demonstrated [14, 15] . In this regard IL-4 and IL-13 induce 15-LU expression and activity, whereas IFN-y blocks this induction. The current findings extend the previous observations by demonstrating contrasting effects on monocyte arachidonate 5-LU pathway by proinflammatory and TH-2-derived cytokines. The elucidation of IL-4 and IL-13 as key regulators in the 5-LU pathway is an important step in understanding the regulation between the 5-and 15-LU pathways. In Figure 7 we propose a schematic representation to highlight the effects of selected cytokines on the key biosynthetic enzymes, accessory proteins, and bioactive products of the 5-and 15-LU pathways. 
